FDA inspection
Rubicon Research Private Limited: FDA inspection ending Jan 27, 2023
FDA inspection 1195650 · Voluntary Action Indicated (VAI) · Satara
Key facts
| Inspection ID | 1195650 |
|---|---|
| Firm | Rubicon Research Private Limited |
| FEI number | 3012953979 |
| Address | J - 4/2 Additional Midc |
| City | Satara |
| Fiscal year | 2023 |
| Inspection end date | Jan 27, 2023 |
| Classification | Voluntary Action Indicated (VAI) |
| Project area | Generic Drug Evaluation |
| Product type | Drugs |
At a glance
- 1–9 Citations
- 1–9 Posted citations
- No Warning letter followed
- Yes Form FDA 483 issued
- Yes Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data